Market News AIOpen the app

FDA Approves Teva's IGALMI for At-Home Use

TrialRead the original at globenewswire.com
Good for TEVA

The FDA approved IGALMI for at-home use, giving Teva a new setting for the treatment. The trial met its safety goal, but Teva has not yet shared plans to sell it for at-home use.

TEVA · Teva Pharmaceutical Industries Ltd.

AI read · Good for TEVA

The AI's read

This approval lets IGALMI be used outside a healthcare setting, opening a new way for Teva to offer the treatment. The Phase 3 trial met its safety and tolerability goal, supporting the change. Teva has not shared its plans to sell the at-home version, so its sales contribution is not yet known.

Get alerts for TEVA

Follow Teva Pharmaceutical Industries Ltd. (TEVA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TEVA
Free on the App Store and Google Play, or on the web.